Favourites   Have ideas?  Sign in / Register

Positive:

Negative:


Dermatology segment

CARA Cara Therapeutics, Inc. - Common Stock 2.98% up -10.55% 13.53 + Medicine, Disease: Kidney, Disease: Liver, Skin, Dermatology


Last highlighted: Form 8-K: Regulation FD Disclosure. On April 29, 2021, Cara Therapeutics issued a press release announcing topline.. $CARA https://t.co/cUtiqqrXat
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.